Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Status:
Completed
Trial end date:
2015-09-16
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as bendamustine hydrochloride and dexamethasone,
work in different ways to stop the growth of cancer cells, either by killing the cells or by
stopping them from dividing. Lenalidomide may stimulate the immune system in different ways
and stop cancer cells from growing. Giving bendamustine hydrochloride together with
lenalidomide and dexamethasone may kill more cancer cells. PURPOSE: This phase I/II trial is
studying the side effects and best dose of bendamustine hydrochloride and lenalidomide when
given together with dexamethasone and to see how well they work in treating patients with
relapsed multiple myeloma.